131 related articles for article (PubMed ID: 38474089)
21. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Wang M; Fuhrmann J; Thompson PR
Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
[TBL] [Abstract][Full Text] [Related]
22. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
Chung J; Karkhanis V; Baiocchi RA; Sif S
J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
[TBL] [Abstract][Full Text] [Related]
23. Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.
Ichikawa T; Nakahata S; Fujii M; Iha H; Morishita K
Sci Rep; 2015 Aug; 5():12841. PubMed ID: 26269411
[TBL] [Abstract][Full Text] [Related]
24. PRMT1 loss sensitizes cells to PRMT5 inhibition.
Gao G; Zhang L; Villarreal OD; He W; Su D; Bedford E; Moh P; Shen J; Shi X; Bedford MT; Xu H
Nucleic Acids Res; 2019 Jun; 47(10):5038-5048. PubMed ID: 30916320
[TBL] [Abstract][Full Text] [Related]
25. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
[TBL] [Abstract][Full Text] [Related]
26. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
[TBL] [Abstract][Full Text] [Related]
27. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.
Aggarwal P; Vaites LP; Kim JK; Mellert H; Gurung B; Nakagawa H; Herlyn M; Hua X; Rustgi AK; McMahon SB; Diehl JA
Cancer Cell; 2010 Oct; 18(4):329-40. PubMed ID: 20951943
[TBL] [Abstract][Full Text] [Related]
28. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
Ho MC; Wilczek C; Bonanno JB; Xing L; Seznec J; Matsui T; Carter LG; Onikubo T; Kumar PR; Chan MK; Brenowitz M; Cheng RH; Reimer U; Almo SC; Shechter D
PLoS One; 2013; 8(2):e57008. PubMed ID: 23451136
[TBL] [Abstract][Full Text] [Related]
29. PRMT5 activates AKT via methylation to promote tumor metastasis.
Huang L; Zhang XO; Rozen EJ; Sun X; Sallis B; Verdejo-Torres O; Wigglesworth K; Moon D; Huang T; Cavaretta JP; Wang G; Zhang L; Shohet JM; Lee MM; Wu Q
Nat Commun; 2022 Jul; 13(1):3955. PubMed ID: 35803962
[TBL] [Abstract][Full Text] [Related]
30. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.
Guderian G; Peter C; Wiesner J; Sickmann A; Schulze-Osthoff K; Fischer U; Grimmler M
J Biol Chem; 2011 Jan; 286(3):1976-86. PubMed ID: 21081503
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiological significance of N-myc downstream-regulated gene 2 in cancer development through protein phosphatase 2A phosphorylation regulation.
Morishita K; Nakahata S; Ichikawa T
Cancer Sci; 2021 Jan; 112(1):22-30. PubMed ID: 33128318
[TBL] [Abstract][Full Text] [Related]
32. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
33. Expression of mep50 in adult and embryos of medaka fish (Oryzias latipes).
Cheng N; Guo M; Chang P; Zhang X; Zhang R; Qi C; Zhong X; Zhou Q; Zhao H
Fish Physiol Biochem; 2016 Jun; 42(3):1053-61. PubMed ID: 26749004
[TBL] [Abstract][Full Text] [Related]
34. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
[TBL] [Abstract][Full Text] [Related]
35. The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions.
Chakrapani B; Khan MIK; Kadumuri RV; Gupta S; Verma M; Awasthi S; Govindaraju G; Mahesh A; Rajavelu A; Chavali S; Dhayalan A
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376131
[TBL] [Abstract][Full Text] [Related]
36. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
[TBL] [Abstract][Full Text] [Related]
37. Protein arginine methyltransferase Prmt5-Mep50 methylates histones H2A and H4 and the histone chaperone nucleoplasmin in Xenopus laevis eggs.
Wilczek C; Chitta R; Woo E; Shabanowitz J; Chait BT; Hunt DF; Shechter D
J Biol Chem; 2011 Dec; 286(49):42221-42231. PubMed ID: 22009756
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.
Alinari L; Mahasenan KV; Yan F; Karkhanis V; Chung JH; Smith EM; Quinion C; Smith PL; Kim L; Patton JT; Lapalombella R; Yu B; Wu Y; Roy S; De Leo A; Pileri S; Agostinelli C; Ayers L; Bradner JE; Chen-Kiang S; Elemento O; Motiwala T; Majumder S; Byrd JC; Jacob S; Sif S; Li C; Baiocchi RA
Blood; 2015 Apr; 125(16):2530-43. PubMed ID: 25742700
[TBL] [Abstract][Full Text] [Related]
39. Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.
Krzyzanowski A; Esser LM; Willaume A; Prudent R; Peter C; 't Hart P; Waldmann H
J Med Chem; 2022 Nov; 65(22):15300-15311. PubMed ID: 36378254
[TBL] [Abstract][Full Text] [Related]
40. Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.
Beketova E; Fang S; Owens JL; Liu S; Chen X; Zhang Q; Asberry AM; Deng X; Malola J; Huang J; Li C; Pili R; Elzey BD; Ratliff TL; Wan J; Hu CD
Cancer Res; 2020 Nov; 80(22):4904-4917. PubMed ID: 32999000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
